Little is known about the molecular basis of antibiotic resistance among uropathogens in Southeast Nigeria. The aim of the study was to characterize enterobacterial uropathogens with respect to drug resistance. One hundred (100) enterobacterial uropathogens were studied. Their antibiotic susceptibility patterns were evaluated using disk diffusion, screened, and confirmed phenotypically for the presence of β-lactamases: ESBL, AmpC, carbapenemase, and MBLs. Screen positives were further tested for various β-lactamase genes by PCR. Our isolates showed variable resistance to most drugs tested. Out of the 58 ESBL screen positive E. coli, 35 were confirmed positive with PCR. The predominant ESBL gene was blaTEM while blaSPM was the most prevalent...
BackgroundBacteremia is a leading cause of mortality in developing countries, however, etiologic eva...
Background: Extended spectrum beta-lactamases are produced by Gram-negative bacteria and most strain...
Background: Multidrug resistant bacteria continue to be a bane in the treatment of clinical infectio...
Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are of major concern as they are i...
The increase in antimicrobial resistance in developed and developing countries is a global public he...
Background: Extended-Spectrum â-Lactamases (ESBLs) are group of enzymes produced by bacterial specie...
Abstract Infections caused by multi-drug resistant Enterobacterales (MDR-E) are difficult to treat a...
Infections of the urinary tract have been on the rise globally and these are also worsened by the in...
The emergence of extended-spectrum-β-lactamases (ESBLs)-producing Escherichia coli represents a seri...
Background: The emergence and spread of extended-spectrum beta-lactamase (ESBL) producing Enterobact...
Background: The prevalence of ESBLs-producing Escherichia coli has recently increased worldwide due ...
SummaryObjectivesThis study was carried out to determine a point prevalence of drug resistance and e...
The emergence of extended-spectrum-β-lactamases (ESBLs)-producing Escherichia coli represents a...
Background: Extended Spectrum Beta-Lactamases (ESBLs) producing Gram-negative uropathogens is now a...
Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical path...
BackgroundBacteremia is a leading cause of mortality in developing countries, however, etiologic eva...
Background: Extended spectrum beta-lactamases are produced by Gram-negative bacteria and most strain...
Background: Multidrug resistant bacteria continue to be a bane in the treatment of clinical infectio...
Extended Spectrum β-lactamase (ESBL)-producing Enterobacteriaceae are of major concern as they are i...
The increase in antimicrobial resistance in developed and developing countries is a global public he...
Background: Extended-Spectrum â-Lactamases (ESBLs) are group of enzymes produced by bacterial specie...
Abstract Infections caused by multi-drug resistant Enterobacterales (MDR-E) are difficult to treat a...
Infections of the urinary tract have been on the rise globally and these are also worsened by the in...
The emergence of extended-spectrum-β-lactamases (ESBLs)-producing Escherichia coli represents a seri...
Background: The emergence and spread of extended-spectrum beta-lactamase (ESBL) producing Enterobact...
Background: The prevalence of ESBLs-producing Escherichia coli has recently increased worldwide due ...
SummaryObjectivesThis study was carried out to determine a point prevalence of drug resistance and e...
The emergence of extended-spectrum-β-lactamases (ESBLs)-producing Escherichia coli represents a...
Background: Extended Spectrum Beta-Lactamases (ESBLs) producing Gram-negative uropathogens is now a...
Two major hospitals in Kano, North West Nigeria have recorded increasing resistance of clinical path...
BackgroundBacteremia is a leading cause of mortality in developing countries, however, etiologic eva...
Background: Extended spectrum beta-lactamases are produced by Gram-negative bacteria and most strain...
Background: Multidrug resistant bacteria continue to be a bane in the treatment of clinical infectio...